US Stock MarketDetailed Quotes

CHRO Chromocell Therapeutics

Watchlist
  • 0.642
  • +0.022+3.50%
Close Nov 1 16:00 ET
3.70MMarket Cap-381P/E (TTM)

Chromocell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1,424.85%-2.95M
-1,048.93%-1.99M
37.40%-981.03K
46.48%-356.81K
0.22%-257.24K
33.56%-193.62K
50.65%-173.37K
1.62%-1.57M
-114.48%-666.62K
-257.79K
Net income from continuing operations
-85.83%-1.77M
-165.10%-2.56M
-200.20%-7.38M
-221.22%-4.04M
-155.41%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-312.94%-2.46M
-498.87%-1.26M
---556.66K
Other non cash items
--0
1,813.52%605.63K
177.52%389.72K
657.85%322.93K
-386.51%-108.34K
283.60%143.47K
40.01%31.65K
--140.43K
--42.61K
--37.81K
Change In working capital
-667.56%-1.64M
-166.98%-327.75K
220.05%2.05M
24.19%544.04K
179.18%728.8K
5,406.33%288.92K
870.74%489.32K
184.79%640.86K
534.39%438.05K
--261.05K
-Change in prepaid assets
--62.83K
---220.93K
----
----
----
--0
--0
----
----
----
-Change in payables and accrued expense
-689.30%-1.7M
-121.83%-106.82K
220.05%2.05M
24.19%544.04K
351.67%728.8K
3,480.14%288.92K
1,365.74%489.32K
177.43%640.86K
534.39%438.05K
--161.36K
Cash from discontinued investing activities
Operating cash flow
-1,424.85%-2.95M
-1,048.93%-1.99M
37.40%-981.03K
46.48%-356.81K
0.22%-257.24K
33.56%-193.62K
50.65%-173.37K
1.62%-1.57M
-114.48%-666.62K
---257.79K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
599.54%1.59M
3,294.63%5.67M
-36.98%1.02M
-21.52%430.41K
-53.78%198.13K
-22.77%226.91K
-52.49%166.9K
1.83%1.62M
76.46%548.45K
428.64K
Net issuance payments of debt
599.54%1.59M
-228.67%-214.76K
91.73%766.94K
75.00%175K
--198.13K
--226.91K
-44.37%166.9K
--400K
--100K
--0
Net common stock issuance
--0
--5.88M
--255.41K
----
----
--0
--0
--0
----
----
Net other financing activities
----
----
----
----
----
----
----
-23.28%1.22M
44.28%448.45K
--428.64K
Cash from discontinued financing activities
Financing cash flow
599.54%1.59M
3,294.63%5.67M
-36.98%1.02M
-21.52%430.41K
-53.78%198.13K
-22.77%226.91K
-52.49%166.9K
1.83%1.62M
76.46%548.45K
--428.64K
Net cash flow
Beginning cash position
7,656.40%3.77M
75.02%96.39K
--55.07K
-86.85%22.79K
3,330.79%81.89K
--48.61K
--55.07K
--0
--173.24K
--2.39K
Current changes in cash
-4,201.34%-1.37M
56,917.79%3.67M
-24.98%41.32K
162.29%73.61K
-134.60%-59.11K
--33.29K
---6.47K
--55.07K
---118.17K
--170.85K
End cash Position
2,836.88%2.41M
7,656.40%3.77M
75.02%96.39K
75.02%96.39K
-86.85%22.79K
3,330.79%81.89K
--48.61K
--55.07K
--55.07K
--173.24K
Free cash flow
-1,424.85%-2.95M
-1,048.93%-1.99M
37.40%-981.03K
46.48%-356.81K
0.22%-257.24K
33.56%-193.62K
50.65%-173.37K
1.62%-1.57M
-114.48%-666.62K
---257.79K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1,424.85%-2.95M-1,048.93%-1.99M37.40%-981.03K46.48%-356.81K0.22%-257.24K33.56%-193.62K50.65%-173.37K1.62%-1.57M-114.48%-666.62K-257.79K
Net income from continuing operations -85.83%-1.77M-165.10%-2.56M-200.20%-7.38M-221.22%-4.04M-155.41%-1.42M-185.39%-953.35K-211.34%-966.56K-312.94%-2.46M-498.87%-1.26M---556.66K
Other non cash items --01,813.52%605.63K177.52%389.72K657.85%322.93K-386.51%-108.34K283.60%143.47K40.01%31.65K--140.43K--42.61K--37.81K
Change In working capital -667.56%-1.64M-166.98%-327.75K220.05%2.05M24.19%544.04K179.18%728.8K5,406.33%288.92K870.74%489.32K184.79%640.86K534.39%438.05K--261.05K
-Change in prepaid assets --62.83K---220.93K--------------0--0------------
-Change in payables and accrued expense -689.30%-1.7M-121.83%-106.82K220.05%2.05M24.19%544.04K351.67%728.8K3,480.14%288.92K1,365.74%489.32K177.43%640.86K534.39%438.05K--161.36K
Cash from discontinued investing activities
Operating cash flow -1,424.85%-2.95M-1,048.93%-1.99M37.40%-981.03K46.48%-356.81K0.22%-257.24K33.56%-193.62K50.65%-173.37K1.62%-1.57M-114.48%-666.62K---257.79K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 599.54%1.59M3,294.63%5.67M-36.98%1.02M-21.52%430.41K-53.78%198.13K-22.77%226.91K-52.49%166.9K1.83%1.62M76.46%548.45K428.64K
Net issuance payments of debt 599.54%1.59M-228.67%-214.76K91.73%766.94K75.00%175K--198.13K--226.91K-44.37%166.9K--400K--100K--0
Net common stock issuance --0--5.88M--255.41K----------0--0--0--------
Net other financing activities -----------------------------23.28%1.22M44.28%448.45K--428.64K
Cash from discontinued financing activities
Financing cash flow 599.54%1.59M3,294.63%5.67M-36.98%1.02M-21.52%430.41K-53.78%198.13K-22.77%226.91K-52.49%166.9K1.83%1.62M76.46%548.45K--428.64K
Net cash flow
Beginning cash position 7,656.40%3.77M75.02%96.39K--55.07K-86.85%22.79K3,330.79%81.89K--48.61K--55.07K--0--173.24K--2.39K
Current changes in cash -4,201.34%-1.37M56,917.79%3.67M-24.98%41.32K162.29%73.61K-134.60%-59.11K--33.29K---6.47K--55.07K---118.17K--170.85K
End cash Position 2,836.88%2.41M7,656.40%3.77M75.02%96.39K75.02%96.39K-86.85%22.79K3,330.79%81.89K--48.61K--55.07K--55.07K--173.24K
Free cash flow -1,424.85%-2.95M-1,048.93%-1.99M37.40%-981.03K46.48%-356.81K0.22%-257.24K33.56%-193.62K50.65%-173.37K1.62%-1.57M-114.48%-666.62K---257.79K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data